114935-28-3

Upstream product

• 114935-21-6 2,5-di-O-benzyl-1,6-bis-O-(4-methoxy-benzyl)-D-mannitol 
• 114935-18-1 2,5-di-O-benzyl-1,3(R):4,6(R)-bis-O-(4-methoxy-benzylidene)-D-mannitol 
• 114935-25-0 (S)-2-benzyloxy-3-(4-methoxy-benzyloxy)-propan-1-ol 
• 100-39-0 benzyl bromide 
• 322468-17-7 (R)-2-O-benzyl-3-O-tritylglycerol aldehyde 
• 90126-86-6 2,5-di-O-benzyl-1,6-di-O-trityl-D-mannitol 
• 114978-02-8 2,5-di-O-benzyl-1,3(R):4,6(R)-di-O-benzylidene-D-mannitol 
• 13383-07-8 (S)-2-O-benzyl-3-O-tritylglycerol aldehyde 
• 17618-04-1 2,5-di-O-benzyl-D-mannitol 
• 106731-74-2 tert-butyl[(2S)-oxiran-2-ylmethoxy]diphenylsilane 
• 100-51-6 benzyl alcohol 
• 114935-24-9 (R)-2-benzyloxy-1-tert-butyldiphenylsilanyloxy-3-(4-methoxy-benzyloxy)-propane 

Downstream Products

• 322468-27-9 ((S)-2-O-benzyl-glyceryl)-2-bromoethyl-methylphosphate 
• 322468-31-5 (3-O-[2-(4-isobutlyphenyl propanoyl)]-(S)-2-O-benzylglyceryl)-2-bromoethyl-methyl phosphate 
• 322468-23-5 ((S)-2-O-benzyl-3-O-tertbutyldiphenylsilylglyceryl)-2-bromoethyl-methylphosphate 

Relevant academic research and scientific papers

Drug-phospholipid conjugates as potential prodrugs: Synthesis, characterization, and degradation by pancreatic phospholipase A2

The aim of the present study was the synthesis of phospholipids containing a drug molecule instead of a fatty acid. Valproic acid and ibuprofen served as model compounds. The target molecules were synthesized either starting from sn-glycero-3-phosphocholi